Kashif Ali
Pediatrics · Houston, TXNPI 1235248873
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $258 and has fallen 77.1% since, to $59 in 2025.
Across 28 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$118
- E.r. Squibb & Sons, L.L.C.$110
- Incyte Corporation$103
- Cranial Technologies, Inc$96
- Exelixis Inc.$44
- GSK$38
- plus $96 from 5 others
Across 1,481 payments — averaging $12,929 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$14.3M
- Pfizer$3.8M
- Sanofi Pasteur Inc.$306K
- GSK$235K
- Merck$225K
- Eli Lilly$157K
- plus $152K from 3 others
What the payments were for
- Food & beverage$59999%
- Education$61%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 6 | $118 |
| E.r. Squibb & Sons, L.L.C. | 1 | $110 |
| Incyte Corporation | 5 | $103 |
| Cranial Technologies, Inc | 7 | $96 |
| Exelixis Inc. | 2 | $44 |
| GSK | 2 | $38 |
| Sobi, Inc | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Merck | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$110
How this compares
$604 in reported general payments places this provider in the 70th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Houston
- Pedro PiedraHouston$729K
- Vernon SuttonHouston$90K
- Carlos BacinoHouston$53K
- Farida AbidHouston$50K
- Lindsay CameronHouston$32K
- Juan Torres SanchezHouston$31K
- Martin YudovichHouston$24K
- Raegan HuntHouston$23K
- Michael PickettHouston$14K
- Lara LeonhardtHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.